Skip to main content

Q&As in

Gastro Learning Network
May 20, 2020
In a new study, researchers sought to clarify how the gut microbe may influence chronic gastrointestinal disease. The coauthors Michael C. Hoaglin, MD and Melissa Agnello, PhD answered our questions about their research.
Gastro Learning Network
March 31, 2020
Joshua Z. Goldenberg, ND, answered our questions about his team’s study aimed to assess the efficacy and safety of biofeedback-based interventions for treating irritable bowel syndrome among adults and children.
Gastro Learning Network
March 10, 2020
Maitreyi Raman, MD, MSc, answers our questions about how the low FODMAP diet affects irritable bowel syndrome symptoms, concerns about prescribing the low FODMAP diet, and factors that need to be considered before prescribing the low FODMAP diet.
Gastro Learning Network
December 09, 2019
Michael Camilleri, MD, from the Mayo Clinic, answers our questions about his research on fecal bile acids and fecal fat as potential biomarkers for irritable bowel syndrome, the importance of individualized treatment, and more.
Gastro Learning Network
November 18, 2019
Magnus Simrén, MD, PhD, answers our questions about his research that assessed whether human milk oligosaccharides could improve bowel symptoms in patients with irritable bowel syndrome.
Gastro Learning Network
September 10, 2019
Sarah Ballou, PhD, answers our questions about her research on the effects of IBS on daily function between disease subtypes, as well as about current IBS management challenges and more.
Gastro Learning Network
August 07, 2019
Rachel Adams, MS, RD, answers our questions on her research about how individuals with irritable bowel syndrome relate their symptoms to diet, as well as the role of diet in the overall management of the condition.
Gastro Learning Network
June 07, 2019
Marissa Holden, an MD candidate at the University of California, Los Angeles, answers our questions about a new study that evaluated the relationship between the autonomic nervous system and bowel function, gut microbiota, and cortisol response in irritable bowel syndrome.
Back to Top